Curetalks - Page 5 of 46 - Discussions for Solutions

Past CureTalks

Early Age Onset Colorectal Cancer – Trends and Challenges

Colorectal cancer is a term that includes colon and rectal cancers, both of which originate in the lower portion of the large intestine and into the rectum. Colorectal cancer (CRC) incidence in the United States is declining rapidly overall but,…

Feb 03, 2022, 02:00 pm 0 Listen

Understanding the approach to integrative oncology

Research suggests that cancer patients are interested in using additional interventions that may help improve the efficacy of conventional cancer treatments, increase their chance of survival, and/or reduce their symptom burden associated with cancer or treatments. They are also looking…

Jan 07, 2022, 02:00 pm 0 Listen

Waldenstrom’s Macroglobulinemia: Advances in Treatments

Waldenstrom’s macroglobulinemia (WM) is a lymphoma, or cancer of the lymphatic system. The disease begins in a type of white blood cell called a B-lymphocyte, which normally matures into a plasma cell. In WM, there is a malignant change to…

Dec 01, 2021, 01:00 pm 0 Listen

In a Race to Cure HIV : Gene Therapy, Vaccines and Other Approaches

Progress in antiretroviral therapy has considerably reduced mortality and notably improved the quality of life of individuals infected with HIV . However, drug resistance, treatment-associated toxicity, adherence to medication, and the need for lifelong therapy have remained major challenges. While…

Nov 22, 2021, 09:00 am 0 Listen

Off-the-shelf Immune Drug for Aggressive Multiple Myeloma: Teclistamab

U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for teclistamab in the treatment of relapsed or refractory multiple myeloma. This follows a PRIME (PRIority MEdicines) designation from the European Medicines Agency (EMA) received earlier this year. …

Nov 03, 2021, 12:00 pm 0 Listen